Literature DB >> 9212360

Temporal discontinuities in progression of NOD autoimmune diabetes.

G B Rudy1, R M Sutherland, A M Lew.   

Abstract

Consideration of the pathophysiology of insulin-dependent diabetes mellitus in the nonobese diabetic (NOD) mouse can be viewed from a temporal perspective. We argue that there are discontinuous phases and each phase may reflect a phenotype educed by a particular set of genetic and epigenetic events. Therefore, temporal dissection may be a useful platform for causal dissection and we have set out this article as follows: 1. Introduction. 2. "Pre-time." a. Genetics. b. Parental effects. 3. Development of insulitis. a. Development of autoimmunity vs waning of or failure to establish tolerance. b. Importance of beta cell mass. c. Homing. 4. Onset of beta cell destruction. 5. Further Discussion.

Entities:  

Mesh:

Year:  1997        PMID: 9212360     DOI: 10.1007/bf02786358

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  64 in total

1.  CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes.

Authors:  D J Lenschow; K C Herold; L Rhee; B Patel; A Koons; H Y Qin; E Fuchs; B Singh; C B Thompson; J A Bluestone
Journal:  Immunity       Date:  1996-09       Impact factor: 31.745

2.  Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice.

Authors:  T Koike; Y Itoh; T Ishii; I Ito; K Takabayashi; N Maruyama; H Tomioka; S Yoshida
Journal:  Diabetes       Date:  1987-04       Impact factor: 9.461

3.  The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice.

Authors:  A Signore; P Pozzilli; E A Gale; D Andreani; P C Beverley
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

4.  Polygenic control of autoimmune diabetes in nonobese diabetic mice.

Authors:  S Ghosh; S M Palmer; N R Rodrigues; H J Cordell; C M Hearne; R J Cornall; J B Prins; P McShane; G M Lathrop; L B Peterson
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

5.  The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom.

Authors:  A K Foulis; C N Liddle; M A Farquharson; J A Richmond; R S Weir
Journal:  Diabetologia       Date:  1986-05       Impact factor: 10.122

6.  Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes.

Authors:  L S Wicker; E H Leiter; J A Todd; R J Renjilian; E Peterson; P A Fischer; P L Podolin; M Zijlstra; R Jaenisch; L B Peterson
Journal:  Diabetes       Date:  1994-03       Impact factor: 9.461

7.  Anti-alpha/beta T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) mice.

Authors:  P Sempé; P Bédossa; M F Richard; M C Villà; J F Bach; C Boitard
Journal:  Eur J Immunol       Date:  1991-05       Impact factor: 5.532

8.  Anti-interleukin 2 receptor antibody suppresses murine diabetic insulitis and lupus nephritis.

Authors:  V E Kelley; G N Gaulton; M Hattori; H Ikegami; G Eisenbarth; T B Strom
Journal:  J Immunol       Date:  1988-01-01       Impact factor: 5.422

9.  Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells.

Authors:  A Bendelac; C Carnaud; C Boitard; J F Bach
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

10.  T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice.

Authors:  C Boitard; R Yasunami; M Dardenne; J F Bach
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.